9-fluoro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4740752

PubChem CID: 162645101

Max Phase: Preclinical

Molecular Formula: C23H24FN7O2

Molecular Weight: 449.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1ccc(F)cc1NC(=O)N2

Standard InChI:  InChI=1S/C23H24FN7O2/c1-30-7-9-31(10-8-30)15-4-6-17(20(12-15)33-2)26-22-25-13-19-21(29-22)16-5-3-14(24)11-18(16)27-23(32)28-19/h3-6,11-13H,7-10H2,1-2H3,(H,25,26,29)(H2,27,28,32)

Standard InChI Key:  LFRUTXNNYRSFEI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    5.8716   -3.2440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8705   -4.0635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5785   -4.4725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5767   -2.8351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2884   -4.0644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2854   -3.2404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9304   -2.7184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7382   -2.8936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0996   -3.6371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7474   -4.3874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9423   -4.5751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7038   -5.3648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2695   -5.9674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0768   -5.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3115   -4.9857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2431   -2.2510    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1625   -4.4715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1618   -5.2887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4537   -5.6952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4527   -6.5116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1606   -6.9216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8710   -6.5092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8685   -5.6941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7467   -5.2853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0382   -5.6926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1610   -7.7388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4509   -8.1445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4494   -8.9582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1555   -9.3702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8648   -8.9624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8680   -8.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1528  -10.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6385   -6.3686    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 14 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4740752

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.49Molecular Weight (Monoisotopic): 449.1976AlogP: 3.74#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.60CX Basic pKa: 7.84CX LogP: 3.31CX LogD: 2.74
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.41

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source